Ruiz Lynnette A, Báez-Vega Perla M, Ruiz Abigail, Peterse Daniëlle P, Monteiro Janice B, Bracero Nabal, Beauchamp Pedro, Fazleabas Asgerally T, Flores Idhaliz
Department of Anatomy, Ponce Health Sciences University-School of Medicine & Ponce Research Institute, Ponce, PR, USA.
Comprehensive Cancer Center, Medical Sciences Campus, University of Puerto Rico, San Juan, PR, USA.
Reprod Sci. 2015 Dec;22(12):1496-508. doi: 10.1177/1933719115585144. Epub 2015 May 11.
Lysyl oxidases (LOXs) are enzymes involved in collagen deposition, extracellular membrane remodeling, and invasive/metastatic potential. Previous studies reveal an association of LOXs and endometriosis. We aimed to identify the mechanisms activated by upregulation of lysyl oxidases (LOX) in endometriotic cells and tissues. We hypothesized that LOX plays a role in endometriosis by promoting invasiveness and epithelial to mesenchymal transition (EMT).
The LOX protein expression levels were measured by immunohistochemistry in lesions and endometrium on a tissue microarray (TMA) and in endometrial biopsies from patients and controls during the window of implantation (WOI). Estradiol regulation of LOX expression was determined by quantitative polymerase chain reaction (qPCR). Proliferation, invasion, and migration assays were performed in epithelial (endometrial epithelial cell), endometrial (human endometrial stromal cell), and endometriotic cell lines (ECL and 12Z). Pathway-focused multiplex qPCR was used to determine transcriptome changes due to LOX overexpression.
LOX protein was differentially expressed in ovarian versus peritoneal lesions. During WOI, LOX levels were higher in luminal epithelium of patients with endometriosis-associated infertility compared to controls. Invasive epithelial cell lines expressed higher levels of LOX than noninvasive ones. Transfection of LOX into noninvasive epithelial cells increased their migration in an LOX inhibitor-sensitive manner. Overexpression of LOX did not fully induce EMT but the expression of genes related to fibrosis and extracellular matrix remodeling were dysregulated.
This study documents that expression of LOX is differentially regulated in endometriotic lesions and endometrium. A role for LOX in mediating proliferation, migration, and invasion of endometrial and endometriotic cells was observed, which may be implicated in the establishment and progression of endometriotic lesions.
赖氨酰氧化酶(LOXs)是参与胶原蛋白沉积、细胞外膜重塑以及侵袭/转移潜能的酶。先前的研究揭示了LOXs与子宫内膜异位症之间的关联。我们旨在确定子宫内膜异位细胞和组织中赖氨酰氧化酶(LOX)上调所激活的机制。我们假设LOX通过促进侵袭和上皮-间质转化(EMT)在子宫内膜异位症中发挥作用。
通过免疫组织化学在组织微阵列(TMA)上的病变和子宫内膜以及植入窗(WOI)期间患者和对照的子宫内膜活检中测量LOX蛋白表达水平。通过定量聚合酶链反应(qPCR)确定雌二醇对LOX表达的调节。在上皮细胞(子宫内膜上皮细胞)、子宫内膜细胞(人子宫内膜基质细胞)和子宫内膜异位细胞系(ECL和12Z)中进行增殖、侵袭和迁移试验。使用通路聚焦多重qPCR来确定由于LOX过表达引起的转录组变化。
LOX蛋白在卵巢病变与腹膜病变中差异表达。在WOI期间,与对照相比,子宫内膜异位症相关不孕症患者的腔上皮中LOX水平更高。侵袭性上皮细胞系比非侵袭性上皮细胞系表达更高水平的LOX。将LOX转染到非侵袭性上皮细胞中以对LOX抑制剂敏感的方式增加了它们的迁移。LOX的过表达并未完全诱导EMT,但与纤维化和细胞外基质重塑相关的基因表达失调。
本研究证明LOX在子宫内膜异位病变和子宫内膜中的表达受到差异调节。观察到LOX在介导子宫内膜和子宫内膜异位细胞的增殖、迁移和侵袭中起作用,这可能与子宫内膜异位病变的发生和发展有关。